Fr. 44.50

Our Future is Biotech - A Plain English Guide to How a Tech Revolution is Changing Our Lives

English · Hardback

Shipping usually within 3 to 5 weeks

Description

Read more

Informationen zum Autor Andrew Craig is a best-selling finance author, Founder of personal finance website www.plainenglishfinance.com and Investment Manager of the VT PEF Global Multi-Asset Fund. From January 2015 to May 2021, he was a partner at an investment bank specialising in biotechnology and life sciences. Andrew has worked for leading financial institutions since 1998. He began his finance career at SBC Warburg in the late nineties. Since then, he has held various senior equity roles at leading investment banks, both in London and New York. In that time, Andrew has met with the senior management teams of over one thousand companies and with several hundred professional investors and has regularly been involved in high profile stock market transactions. (These have included the Kingdom of Sweden's sales of Nordea Bank AB in 2013 (totalling $7.6 billion) and the stock market flotation of several dozen companies including the likes of: easyJet, Burberry, Campari, Carluccio's, the Carbon Trust and lastminute.com). Since founding Plain English Finance in 2011, Andrew has appeared in numerous national and specialist financial publications including: The Mail on Sunday, The Mirror, CityAM, The Spectator, Shares and MoneyWeek magazines, YourMoney, This Is Money and Money Observer. He has been interviewed on Bloomberg and Shares Radio and on IG TV, was featured in Russell Brand and Michael Winterbottom's 2015 film "The Emperor's New Clothes" and interviewed by Eamonn Holmes for the Channel 5 programme "How the other half live". Klappentext "In the last century, technology has transformed the human experience across the world. This has been super-charged by the arrival of the internet, smart phones, AI and machine learning, and created trillion-plus dollar companies and household names like Apple, Amazon, Google and Microsoft. Our Future is Biotech explains why biotech is next: because our biggest remaining challenges as a species concern biological systems. Biotech companies will solve our most intractable problems, from cancer, dementia, obesity and diabetes to elderly care, mental health conditions, and even power generation, agricultural production and environmental degradation. Biotech means that we will live better, safer, healthier, wealthier, happier, and longer lives. The industry has already delivered "miracle cures" for several diseases, and there is more to come. But despite this, few people are aware of the phenomenal progress being made. Our Future is Biotech addresses this, explaining what biotech is, what is coming next, and how you might profit from it too. Tech has been the most important theme for human progress for the last century. Biotech is next."--Amazon.ca. Vorwort Tech has been the most important theme for human development for the last several decades. Biotech is next Zusammenfassung Welcome to the biotech revolution In the last century, technology has transformed the human experience across the world. This has been super-charged by the arrival of the internet, smart phones, AI and machine learning, and created trillion-plus dollar companies and household names like Apple, Amazon, Google and Microsoft. Our Future is Biotech explains why biotech is next: because our biggest remaining challenges as a species concern biological systems. Biotech companies will solve our most intractable problems, from cancer, dementia, obesity and diabetes to elderly care, mental health conditions, and even power generation, agricultural production and environmental degradation. Biotech means that we will live better, safer, healthier, wealthier, happier, and longer lives. The industry has already delivered "miracle cures" for several diseases, and there is more to come. But despite this, few people are aware of the phenomenal progress being made. Our Future is Biotech addresses this, explain...

Product details

Authors Andrew Craig
Publisher Brealey, Nicholas
 
Languages English
Product format Hardback
Released 23.11.2023
 
EAN 9781399800174
ISBN 978-1-399-80017-4
No. of pages 272
Dimensions 156 mm x 236 mm x 24 mm
Subjects Social sciences, law, business > Sociology > Sociological theories

Sociology, SOCIAL SCIENCE / General, Business & Economics / Personal Finance / Investing, Science: general issues, SCIENCE / General, MEDICAL / Biotechnology, Investment & securities, Investment and securities, Chemical, biotechnology and pharmaceutical industries

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.